{"id":"mumps-vaccine-live-mv","safety":{"commonSideEffects":[{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Local injection site reactions (pain, erythema, swelling)"},{"rate":null,"effect":"Parotitis"},{"rate":null,"effect":"Rash"}]},"_chembl":{"chemblId":"CHEMBL2109201","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains a weakened (attenuated) strain of mumps virus that replicates in the body without causing disease, triggering both humoral (antibody) and cell-mediated immune responses. This primes the immune system to recognize and neutralize wild-type mumps virus upon natural exposure, preventing infection or reducing disease severity.","oneSentence":"A live attenuated mumps virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against mumps virus.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:41:36.726Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of mumps in children and adults"}]},"trialDetails":[{"nctId":"NCT06208683","phase":"PHASE4","title":"The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students","status":"UNKNOWN","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2023-11-04","conditions":"Mumps, Influenza","enrollment":400},{"nctId":"NCT02861586","phase":"PHASE2","title":"Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine","status":"COMPLETED","sponsor":"Themis Bioscience GmbH","startDate":"2016-08-17","conditions":"Chikungunya Virus Infection","enrollment":263},{"nctId":"NCT03101111","phase":"PHASE2","title":"Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area","status":"COMPLETED","sponsor":"Themis Bioscience GmbH","startDate":"2017-08-09","conditions":"Chikungunya","enrollment":34}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Mumps vaccine, Live (MV)","genericName":"Mumps vaccine, Live (MV)","companyName":"Sinovac Biotech Co., Ltd","companyId":"sinovac-biotech-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"A live attenuated mumps virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against mumps virus. Used for Prevention of mumps in children and adults.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}